Lipidomics Reveals Potential Mechanisms of Intestinal-Targeted Astaxanthin in Ameliorating Metabolic Dysfunction-Associated Steatotic Liver Disease in ApoE–/– Mice
Journal of Agricultural and Food Chemistry · 2026
DOI: 10.1021/acs.jafc.6c03179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2026. Verfasst von Mengxue He und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Nanjing Agricultural University, Nanjing210095, Jiangsu, China. Hauptthemen laut MEDLINE: Apolipoproteins E, Intestinal Mucosa, Fatty Liver. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a major global health burden with an urgent need for effective interventions. Although astaxanthin (AST) exhibits hepatoprotective potential, its efficacy is limited by poor oral bioavailability. This study evaluated an intestine-targeted astaxanthin delivery system (AST-LPs) in HFHC-diet-induced MASLD mice. AST-LPs administration exhibited superior efficacy over free AST in attenuating hepatic steatosis, improving lipid profiles and glucose tolerance, and suppressing inflammation. Lipidomics analysis revealed that AST-LPs preferentially remodeled HFHC-disrupted lipid profiles, particularly cardiolipins, fatty acid esters of hydroxy fatty acids (FAHFAs), and sphingolipids. Mechanistically, AST-LPs modulated the peroxisome proliferator-activated receptor (PPAR) signaling pathway by upregulating PPARα while downregulating PPARγ and fatty acid-binding protein 1 (FABP1), shifting the metabolic balance toward lipid catabolism over storage. Molecular docking confirmed high binding affinities between AST and these core targets. Collectively, these findings suggest that intestinal-targeted AST delivery is a promising multitarget therapeutic strategy for MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Food Science and Technology, Nanjing Agricultural University, Nanjing210095, Jiangsu, China.
- State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Jiangnan University, Wuxi214122, Jiangsu, China.
- Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang443002, Hubei, China.
- School of Food and Health, Beijing Technology and Business University, 100048Beijing, China.
ORCID-Profile: Yuanfa Liu
Förderung
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
He, M., Liu, A., & Liu, Y. (2026). Lipidomics Reveals Potential Mechanisms of Intestinal-Targeted Astaxanthin in Ameliorating Metabolic Dysfunction-Associated Steatotic Liver Disease in ApoE–/– Mice. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c03179
Vancouver
He M, Liu A, Liu Y. Lipidomics Reveals Potential Mechanisms of Intestinal-Targeted Astaxanthin in Ameliorating Metabolic Dysfunction-Associated Steatotic Liver Disease in ApoE–/– Mice. Journal of Agricultural and Food Chemistry. 2026. doi:10.1021/acs.jafc.6c03179
BibTeX
@article{He2026,
author = {He, Mengxue and Liu, Aiyang and Liu, Yuanfa},
title = {Lipidomics Reveals Potential Mechanisms of Intestinal-Targeted Astaxanthin in Ameliorating Metabolic Dysfunction-Associated Steatotic Liver Disease in ApoE–/– Mice},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
doi = {10.1021/acs.jafc.6c03179}
}
EUVIMED